Health
Malaria antibody protects infants but lowers immune response to R21 vaccine, trial finds
Medical Xpress·November 20, 2026

A single intramuscular dose of an experimental malaria monoclonal antibody safely provided infants with strong protection during Mali's six-month malaria season. However, potential interference with the R21 malaria vaccine is putting plans to pursue development of L9LS for this age group on hold, according to results from a clinical trial presented at the annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH).
Read the full story at Medical Xpress →